|| List of recent Test-related patents
|Test script generation|
Disclosed herein are techniques for generating an automated testing script. A request for a performance evaluation of a computer program is accessed.
|Dynamic load testing|
A system includes sending of requests to a computing system based on a first number of users associated with a load test, evaluation of one or more characteristics of the computing system while sending the requests, determination to modify the first number of users to a second number of users based on the one or more evaluated characteristics, and sending of requests to the computing system based on the second number of users.. .
|Methods, devices and systems for approximation and fastening of soft tissue|
Devices and tissue fasteners for approximating and fastening tissue using minimally invasive techniques are disclosed. Methods for approximating and fastening tissue by application of one or more tissue fasteners are also provided.
|Methods and devices for metabolic surgery|
The present disclosure relates to methods and devices for treatment of metabolic and/or gastrointestinal (gi) tract disorders and, more particularly, to surgical methods and devices for the treatment of type 2 diabetes mellitus and barrett's esophagus. Even more particularly, the present disclosure pertains to methods and devices for disrupting or removing cells from the gi tract, and methods and devices for harvesting cells from one section of the gi tract and implanting those cells in another section of the gi tract..
|Quinoline derivative compound, method for preparing same, and pharmaceutical composition containing same|
The present invention relates to a novel quinoline derivative compound, an optical isomer thereof, a pharmaceutically acceptable salt thereof, and a hydrate or a solvate thereof. The novel quinoline derivative compound, the optical isomer thereof, the pharmaceutically acceptable salt thereof, and the hydrate or the solvate thereof accelerates gastrointestinal movement, and thus can effectively prevent or treat gastrointestinal mobility disorders..
The present invention relates to benzylpiperazine derivatives such as compounds of formula (i), which have activity as agonists of the gpr38 receptor and the use of such compounds or pharmaceutical compositions thereof in the preparation of medicaments suitable for the treatment of gastrointestinal disorders.. .
|Prebiotic formulations and methods of use|
The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.
|Driving monitoring system|
A system and method are provided for monitoring driving behavior in real time, which is then used to assign points to a user, such as the driver, a passenger, friends of the driver or passenger, and the like. The assignment of points can be effective at influencing current and future driving behavior of users via gamification and social networking.
|Compositions and methods for treating gastrointestinal motility dysfunction|
Extended release oral dosage forms for the treatment of gastrointestinal motility disorders are described. Active agents which are small molecules, peptides, peptide analogs, and peptide mimetics are formulated for optimal release in the gi tract of subjects with gi motility dysfunction.
|Compositions and methods for treatment of irritable bowel syndrome with 5-aminosalicylate|
Embodiments are directed to compositions and related methods for treating gastrointestinal disorders with a granulated mesalamine formulation. In some embodiments, the gastrointestinal disorder being treated is irritable bowel syndrome (ibs).
|Gastro-retentive drug delivery system for controlled drug release in the stomach and into the upper intestines|
A gastro-retentive drug delivery system for controlled release of drugs in the stomach or upper gastro-intestinal track provides one or more polymers that hydrate and swell to immobilize the drug in situ in a protective, degradable envelope or cocoon. In one embodiment, oppositely charged polyelectroytes are admixed with the drug and filled in a capsule having a dissolution profile in stomach acid at body temperature.
|System and method for ultrasonic testing with a single channel ultrasonic test unit|
A device and method for ultrasonic inspection of a test object is disclosed. A plurality of ultrasonic transducer elements and electrical pulser circuits are provided for generating and transmitting electrical pulses.
|Wireless patient communicator for use in a life critical network|
A portable housing supports a processor coupled to memory for storing medical firmware and wireless radio firmware, first and second radios, a processor, and a power source. Communications are effected between an implantable medical device and the first radio in accordance with program instructions of the medical firmware, and between the second radio and the wireless network in accordance with program instructions of the wireless radio firmware.
|Non-imaging low frequency ultrasonic testing and diagnostic evaluation system|
Disclosed are non-imaging low frequency ultrasound apparatus and methods that extend the range of ultrasonic applications to medical testing and diagnostics. More particularly, apparatus and methods for generating, transmitting and receiving low frequency ultrasound through a test body can be used to generate non-imaging medical mapping of ultrasound signals and medical diagnostics.
|Flexible gastrointestinal videoendoscope|
The invention relates to a compact videoendoscope, which has additional movements on its tip, allowing better utilization of the movements performed in the distal segment of the device. The videoendoscope according to the invention also provides, in addition, an image processor and monitor incorporated to the handle, or proximal part of the device, with light originating from the device itself through leds placed at the distal tip..
|Antisense oligonucleotides against ache in the treatment of gastrointestinal inflammation disorders|
Ache antisense oligonucleotides are used as antiinflammatory agents, such oligonucleotides preferably having the sequence of seq id no:1 and seq id no:7. Methods of treatment of inflammatory conditions, as well as fever, and particularly inflammation of the gastrointestinal tract, are described..
|Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands|
In particular, the substituted spirocyclic piperidine derivatives may be effective in the treatment of diseases or disease states, including narcolepsy or sleep/wake disorders, feeding behavior disorders, eating disorders, obesity, cognition disorders, arousal disorders, memory disorders, mood disorders, mood attention alteration, attention deficit hyperactivity disorder (adhd), alzheimer's disease/dementia, schizophrenia, pain, stress, migraine, motion sickness, depression, psychiatric disorders, epilepsy, gastrointestinal disorders, respiratory disorders, inflammation, and myocardial infarction.. .
|Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders|
The invention provides novel guanylate cyclase-c agonist peptides and their use in the treatment of human diseases including gastrointestinal disorders, inflammation or cancer (e.g., a gastrointestinal cancer). The peptides can be administered either alone or in combination with an inhibitor of cgmp-dependent phosphodiesterase.
|Administration of serine protease inhibitors to the stomach|
The inventors have unexpectedly discovered that shock and/or potential multi-organ failure due to shock can be effectively treated by administration of liquid high-dose protease inhibitor formulations to a location upstream of where pancreatic proteases are introduced into the gastrointestinal tract. Most preferably, administration is directly to the stomach, for example, via nasogastric tube under a protocol effective to treat shock by such administration without the need of providing significant quantities of the protease inhibitor to the jejunum and/or ileum..
|Device for reading barcodes|
An image capture device for capturing an image of a test tube rack comprising a plurality of test tubes each having an individual barcode thereon, the image capture device comprising: an enclosure comprising a transparent window which, in use, is adjacent the test tube rack to be imaged; at least one camera mounted within the enclosure to capture an image through the window; a plurality of light sources mounted within the enclosure to illuminate the window and at least one light blocking element arranged to at least partially block light radiating from at least one of the plurality of light sources, wherein the plurality of light sources and the at least one light blocking element are arranged within the enclosure to provide generally uniform illumination across the whole window and to reduce unwanted reflections.. .
|Apparatus for testing electronic devices|
An apparatus is described for burn-in and/or functional testing of microelectronic circuits of unsingulated wafers. A large number of power, ground, and signal connections can be made to a large number of contacts on a wafer.
|Anti-reflux devices and methods for treating gastro-esophageal reflux disease (gerd)|
Devices, systems, and methods for treating gastro-esophageal reflux disease (gerd) include anti-reflux valves and retainers for securing them within the lumen of the esophagus, stomach, or a hiatal hernia. The retainers contain inflatable balloons, some of which may be enveloped by a flexible shell that is used to secure the balloon to tissue.
|Needle assisted jet injection administration of testosterone compositions|
The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.. .
A sedds or smedds or snedds formulation for drug delivery of a lipophilic therapeutic agent, providing enhanced modulation of solubility, stability, absorption, metabolism, and/or pharmacokinetic profile of the therapeutic agent by formulation with a lipophilic surfactant, a hydrophilic surfactant, one or more solubilizers and, optionally, digestible oils, resulting in higher bioavailability of the therapeutic agent administered to a subject in need of such therapeutic agent. Also described are pharmaceutical compositions containing the formulations and methods of making and methods of using the formulations and pharmaceutical compositions.
|Use and identification of biomarkers for gastrointestinal diseases|
The described invention relates to the identification of biomarkers for gastrointestinal diseases and provides methods utilizing the biomarkers for in drug discovery, monitoring of treatment efficacy, and diagnostics. The invention further provides methods for identifying a therapeutic target to treat ulcerative colitis, colorectal cancer, and crohn's disease..